Why finding a blood test for Alzheimer’s could be the key to new treatments

t larg alzheimers
Image: CNN

Alzheimer’s patients who were at earlier stages of the disease did better than those with more advanced cognitive decline [in clinical trials], says Colin Masters, a neuroscientist at Florey Institute of Neuroscience and Mental Health in Australia who was not involved in the trials. This indicates that the key to finding an effective treatment might be to catch subjects before their condition advances too far.

Thanks to the recent development of new detection technologies that yield more-precise and reliable measurements of circulating proteins, RNAs, and other molecules, the field is hoping to do just that. Using these analytic tools, which weren’t available just a few years ago, multiple labs around the world are now searching for new biomarkers of the disease to develop blood tests that can screen for early signs of Alzheimer’s, differentiate it from conditions with similar symptoms, or track its progression.

Related article:  Searching for answers in the genome of China's mysterious coronavirus


According to Henrik Zetterberg, a biomarkers researcher at the University of Gothenburg in Sweden, improvements in the analysis of protein composition in blood samples have driven an explosion of research—and promising results—over the past decade.

Read full, original post: The Hunt for a Blood Test for Alzheimer’s Disease

Outbreak Daily Digest
Biotech Facts & Fallacies
GLP Podcasts
Infographic: Deaths from COVID-19 are far higher than reported estimates

Infographic: Deaths from COVID-19 are far higher than reported estimates

More than 2.8 million people have lost their lives due to the pandemic, according to a Wall Street Journal analysis ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend